Jimenez Andrew E, Lee Michael S, Owens Jade S, Maldonado David R, Saks Benjamin R, Lall Ajay C, Domb Benjamin G
American Hip Institute Research Foundation, Chicago, Illinois, USA.
American Hip Institute, Chicago, Illinois, USA.
Orthop J Sports Med. 2022 May 10;10(5):23259671221090905. doi: 10.1177/23259671221090905. eCollection 2022 May.
There is limited literature evaluating patient-reported outcomes (PROs) in cigarette smokers undergoing hip arthroscopy for femoroacetabular impingement syndrome (FAIS) at midterm follow-up.
(1) To report minimum 5-year PROs for cigarette-smoking patients who underwent primary hip arthroscopy for FAIS and (2) to compare these results with a propensity-matched control group of never-smoking patients.
Cohort study; Level of evidence, 3.
Data were collected for all patients who underwent primary hip arthroscopy for FAIS between June 2009 and March 2016. Patients were eligible if they indicated that they smoked cigarettes within 1 month of surgery and had minimum 5-year postoperative outcomes for the modified Harris Hip Score, Nonarthritic Hip Score, Hip Outcome Score-Sport Specific Subscale (HOS-SSS), and International Hip Outcome Tool-12 (iHOT-12). The percentages of patients achieving the Patient Acceptable Symptom State (PASS) and maximum outcome improvement satisfaction threshold were recorded. The study group was then propensity matched in a 1:2 ratio to patients who had never smoked for comparison.
Included were 35 patients (35 hips) with a mean age of 39.4 ± 13.0 years and mean follow-up of 64.6 ± 4.1 months. These patients demonstrated significant improvement from preoperatively to a minimum 5-year follow-up for all recorded PROs ( < .05). When compared with 70 control patients (70 hips), smoking patients demonstrated significantly worse preoperative scores for all PROs ( < .05). Study patients also demonstrated worse minimum 5-year scores for all recorded PROs compared with control patients, which did not reach statistical significance but trended toward significance for HOS-SSS (70.4 vs 81.9; = .076) and iHOT-12 (74.7 vs 82.2; = .122). Smoking patients also trended toward lower rates of achieving PASS for the iHOT-12 compared with never-smoking patients (50.0% vs 68.2%; = .120).
Patients who smoked cigarettes and underwent primary hip arthroscopy for FAIS demonstrated significant improvement in PROs at a minimum 5-year follow-up. When compared with a propensity-matched control group of never-smokers, they trended toward lower postoperative HOS-SSS and iHOT-12 scores and lower rates of achieving PASS on the iHOT-12.
关于接受髋关节镜检查治疗股骨髋臼撞击综合征（FAIS）的吸烟者在中期随访时患者报告结局（PROs）的文献有限。
（1）报告因FAIS接受初次髋关节镜检查的吸烟患者至少5年的PROs，（2）将这些结果与倾向评分匹配的从不吸烟患者对照组进行比较。
队列研究；证据等级，3级。
收集2009年6月至2016年3月期间因FAIS接受初次髋关节镜检查的所有患者的数据。如果患者表示在手术前1个月内吸烟，并且改良Harris髋关节评分、非关节炎髋关节评分、髋关节结局评分-运动特定子量表（HOS-SSS）和国际髋关节结局工具-12（iHOT-12）有至少5年的术后结果，则符合纳入标准。记录达到患者可接受症状状态（PASS）和最大结局改善满意度阈值的患者百分比。然后将研究组与从不吸烟的患者按1:2的比例进行倾向评分匹配以进行比较。
纳入35例患者（35髋），平均年龄39.4±13.0岁，平均随访64.6±4.1个月。所有记录的PROs从术前到至少5年随访均有显著改善（P<0.05）。与70例对照患者（70髋）相比，吸烟患者所有PROs的术前评分均显著更差（P<0.05）。研究患者所有记录的PROs的至少5年评分与对照患者相比也更差，虽未达到统计学意义，但HOS-SSS（70.4对81.9；P = 0.076）和iHOT-12（74.7对82.2；P = 0.122）有接近显著的趋势。与从不吸烟的患者相比，吸烟患者在iHOT-12上达到PASS的比例也有降低趋势（50.0%对68.2%；P = 0.120）。
因FAIS接受初次髋关节镜检查的吸烟患者在至少5年随访时PROs有显著改善。与倾向评分匹配的从不吸烟对照组相比，他们术后HOS-SSS和iHOT-12评分有降低趋势，且在iHOT-12上达到PASS 的比例较低。
